Item 9 Labs Corp
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It operates through Cultivation, Franchising, and Corporate segments. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies thr… Read more
Market Cap & Net Worth: Item 9 Labs Corp (INLB)
Item 9 Labs Corp (PINK:INLB) has a market capitalization of $10.24K ($10.24K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #44972 globally and #14182 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Item 9 Labs Corp's stock price $0.00 by its total outstanding shares 102362271 (102.36 Million).
Item 9 Labs Corp Market Cap History: 2015 to 2025
Item 9 Labs Corp's market capitalization history from 2015 to 2025. Data shows change from $266.14 Million to $10.24K (-65.84% CAGR).
Item 9 Labs Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Item 9 Labs Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.59x
Item 9 Labs Corp's market cap is 0.59 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $266.14 Million | $113.02K | -$4.74 Million | 2354.78x | N/A |
| 2016 | $102.36 Million | $324.03K | -$3.13 Million | 315.91x | N/A |
| 2017 | $286.61 Million | $243.93K | -$266.57K | 1175.01x | N/A |
| 2018 | $532.28 Million | $1.38 Million | -$642.28K | 387.03x | N/A |
| 2019 | $97.24 Million | $4.93 Million | -$10.63 Million | 19.71x | N/A |
| 2020 | $201.65 Million | $8.12 Million | -$12.30 Million | 24.83x | N/A |
| 2021 | $113.62 Million | $21.94 Million | -$10.91 Million | 5.18x | N/A |
| 2022 | $12.80 Million | $21.76 Million | -$31.14 Million | 0.59x | N/A |
Competitor Companies of INLB by Market Capitalization
Companies near Item 9 Labs Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Item 9 Labs Corp by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Item 9 Labs Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Item 9 Labs Corp's market cap moved from $266.14 Million to $ 10.24K, with a yearly change of -65.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $10.24K | 0.00% |
| 2024 | $10.24K | -94.74% |
| 2023 | $194.49K | -98.48% |
| 2022 | $12.80 Million | -88.74% |
| 2021 | $113.62 Million | -43.65% |
| 2020 | $201.65 Million | +107.37% |
| 2019 | $97.24 Million | -81.73% |
| 2018 | $532.28 Million | +85.71% |
| 2017 | $286.61 Million | +180.00% |
| 2016 | $102.36 Million | -61.54% |
| 2015 | $266.14 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Item 9 Labs Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.24K USD |
| MoneyControl | $10.24K USD |
| MarketWatch | $10.24K USD |
| marketcap.company | $10.24K USD |
| Reuters | $10.24K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.